Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 890Healthcare 291Technology 152Industrials 123Financial Services 80Basic Materials 69Consumer Cyclical 55Communication Services 34Consumer Defensive 30Energy 27Real Estate 18Utilities 11
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVPRetractable Technologies, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.08 | n/m | — | — | $17M |
| MODDModular Medical, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$0.90 | n/m | — | — | $15M |
| ESLAEstrella Immunopharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$0.17 | n/m | — | — | $14M |
| MRKRMarker Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | −100.0% | −$2.0M | n/m | −$0.10 | n/m | — | — | $14M |
| JSPRJasper Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $8.0M | n/m | $0.0M | n/m | −$13.97 | n/m | — | — | $11M |
| LONALeonaBio, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$21.0M | n/m | −$0.89 | n/m | — | — | $11M |
| PTNPalatin Technologies, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | −100.0% | −$5.0M | −200.0% | −$1.29 | −130.3% | — | — | $10M |
| AIMDAinos, Inc. | Healthcare | Nov 16 | Sep '26 | $1.0M | n/m | −$2.0M | n/m | $0.00 | n/m | -262.1% | — | $9M |
| KYNBKyntra Bio, Inc. | Healthcare | Nov 16 | Sep '26 | $2.0M | +100.0% | $0.0M | −100.0% | $0.04 | n/m | -730.1% | −231.1 pp | $8M |
| CVKDCadrenal Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26pending | — | — | — | — | — | — | — | — | $7M |
| DAREDare Bioscience, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.18 | n/m | — | — | $6M |
| CNSPCNS Pharmaceuticals, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.24 | n/m | — | — | $6M |
| FBLGFibroBiologics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.38 | n/m | — | — | $6M |
| NDRAENDRA Life Sciences Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$1.02 | n/m | — | — | $6M |
| TCRTAlaunos Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$1.0M | n/m | −$0.31 | n/m | — | — | $6M |
| AEONAEON Biopharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | $2.0M | n/m | $0.01 | n/m | — | — | $6M |
| JAGXJaguar Health, Inc. | Healthcare | Nov 16 | Sep '26 | $1.0M | n/m | −$6.0M | n/m | −$9.23 | n/m | — | — | $5M |
| GTBPGT Biopharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$4.0M | −150.0% | −$1.98 | −107.6% | — | — | $4M |
| TRAWTraws Pharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | — | −$4.0M | — | −$0.18 | — | — | — | $4M |
| MGRXMangoceuticals, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.17 | n/m | — | — | $4M |
| SNTISenti Biosciences Holdings, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$12.0M | n/m | −$0.37 | n/m | — | — | $3M |
| APUSApimeds Pharmaceuticals US, Inc. | Healthcare | Nov 16 | Sep '26 | $3.0M | n/m | $34.0M | n/m | $5.93 | n/m | 70.0% | — | $3M |
| IVFINVO Fertility, Inc. | Healthcare | Nov 16 | Sep '26 | $2.22B | +111,050% | −$2.15B | n/m | −$2.44 | n/m | -66.5% | +26.6 pp | $3M |
| AIDX20/20 Biolabs, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.12 | n/m | -365.6% | −174.1 pp | $3M |
| NXGLNexGel, Inc | Healthcare | Nov 16 | Sep '26 | $3.0M | 0.0% | −$1.0M | n/m | −$2.28 | n/m | -79.9% | −55.2 pp | $2M |
| JUNSJupiter Neurosciences, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$7.42 | n/m | — | — | $2M |
| SXTP60 Degrees Pharmaceuticals, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.75 | n/m | — | — | $2M |
| ADGMAdagio Medical Holdings, Inc | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | $18.0M | n/m | −$5.13 | n/m | — | — | $2M |
| RNAZTransCode Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$107.38B | n/m | −$9364.27 | n/m | — | — | $1M |
| VVOSVivos Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $6.0M | −14.3% | −$2.0M | n/m | −$0.07 | n/m | -52.2% | +17.6 pp | $1M |
| ONCOOnconetix, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$32.0M | n/m | −$76.01 | n/m | — | — | $1M |
| APVOAptevo Therapeutics Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$9.0M | n/m | −$5.19 | n/m | — | — | $1M |
| LABTLakewood-Amedex Biotherapeutics Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$1.0M | n/m | −$0.62 | n/m | — | — | $375,516 |
| MTNBMatinas Biopharma Holdings, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$9.35 | n/m | — | — | $365,452 |
| HCWBHCW Biologics Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$2.83 | n/m | — | — | $270,013 |
| CDTCDT Equity Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$288.89 | n/m | — | — | $167,810 |
| GHRSGH Research PLC | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$12.0M | n/m | −$0.18 | n/m | — | — | $1.3B |
| INBXInhibrx Biosciences, Inc. | Healthcare | Nov 13 | Sep '26 | $2.0M | n/m | −$39.0M | n/m | −$2.46 | n/m | — | — | $1.1B |
| JBIOJade Biosciences, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$35.0M | n/m | −$415.39 | n/m | — | — | $979M |
| CADLCandel Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$22.0M | n/m | −$0.28 | n/m | — | — | $424M |
| INDPIndaptus Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$1.0M | n/m | −$0.01 | n/m | — | — | $376M |
| BNTCBenitec Biopharma Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$13.0M | n/m | −$0.26 | n/m | — | — | $284M |
| ELDNEledon Pharmaceuticals, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.03 | n/m | — | — | $167M |
| IMUXImmunic, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$42.0M | n/m | −$0.99 | n/m | — | — | $100M |
| OWLTOwlet, Inc. | Healthcare | Nov 13 | Sep '26 | $30.0M | −6.2% | $1.0M | −75.0% | $0.02 | −84.6% | 4.0% | +0.1 pp | $95M |
| HURATuHURA Biosciences, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.10 | n/m | — | — | $89M |
| TRXBTRex Bio, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | — | −$13.0M | — | −$0.46 | — | — | — | $83M |
| CINGCingulate Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$7.73B | n/m | −$0.53 | n/m | — | — | $69M |
| FBIOFortress Biotech, Inc. | Healthcare | Nov 13 | Sep '26 | $19.0M | +5.6% | −$6.0M | −200.0% | −$0.23 | −309.1% | -37.5% | +1.1 pp | $61M |
| NORDNordicus Partners Corporation | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $54M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.